Hodgkin Lymphoma
From the Journals
Worse PFS when radiation is withheld in early-stage Hodgkin lymphoma
Patients negative for disease on PET scans after two chemotherapy cycles fared better with consolidation radiotherapy.
Conference Coverage
Cell count ratios appear to predict thromboembolism in lymphoma
AMSTERDAM – The findings mean clinicians can look to complete blood count for answers on thromboembolism risk.
From the Journals
Regimen shows promise as salvage for classical HL
Most patients studied responded to the regimen.
News
EC approves BV plus AVD for Hodgkin lymphoma
The approval for this indication is supported by the phase 3 ECHELON-1 trial.
From the Journals
Hidradenitis suppurativa linked to increased lymphoma risk
The risks of Hodgkin, non-Hodgkin, and cutaneous T-cell lymphoma were more common among males than females.
News
CMT provides survival benefit in young HL patients
Combined modality therapy (CMT) can improve survival in young patients with early stage Hodgkin lymphoma (HL), according to research published in...
News
Risk of second cancers in Hodgkin lymphoma survivors
Survivors of childhood Hodgkin lymphoma (HL) have a 14-fold higher risk of second cancers compared to the general population, according to new...
From the Journals
Survivors of childhood Hodgkin lymphoma face 14-fold risk of second cancers
The findings highlight the need to screen high-risk subgroups of cancer survivors.
News
CHMP recommends BV+AVD for Hodgkin lymphoma
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the marketing authorization for...
News
Lymphodepletion improves efficacy of CAR T cells in HL
SAN DIEGO—A phase 1 study suggests lymphodepletion can improve the efficacy of CD30-directed chimeric antigen receptor (CAR) T-cell therapy in...
News
Fludarabine deemed important for CD30.CAR T-cell therapy
SAN DIEGO—Fludarabine is “very important” for lymphodepletion prior to CD30-directed chimeric antigen receptor (CAR) T-cell therapy, according to...